Xenobiotic transporters: ascribing function from gene knockout and mutation studies.

Transporter-mediated absorption, secretion, and reabsorption of chemicals are increasingly recognized as important determinants in the biological activities of many xenobiotics. In recent years, the rapid progress in generating and characterizing mice with targeted deletion of transporters has greatly increased our knowledge of the functions of transporters in the pharmacokinetics/toxicokinetics of xenobiotics. In this introduction, we focus on functions of transporters learned from experiments on knockout mice as well as humans and rodents with natural mutations of these transporters. We limit our discussion to transporters that either directly transport xenobiotics or are important in biliary excretion or cellular defenses, namely multidrug resistance, multidrug resistance-associated proteins, breast cancer resistance protein, organic anion transporting polypeptides, organic anion transporters, organic cation transporters, nucleoside transporters, peptide transporters, bile acid transporters, cholesterol transporters, and phospholipid transporters, as well as metal transporters. Efflux transporters in intestine, liver, kidney, brain, testes, and placenta can efflux xenobiotics out of cells and serve as barriers against the entrance of xenobiotics into cells, whereas many xenobiotics enter the biological system via uptake transporters. The functional importance of a given transporter in each tissue depends on its substrate specificity, expression level, and the presence/absence of other transporters with overlapping substrate preferences. Nevertheless, a transporter may affect a tissue independent of its local expression by altering systemic metabolism. Further studies on the gene regulation and function of transporters, as well as the interrelationship between transporters and phase I/II xenobiotic-metabolizing enzymes, will provide a complete framework for developing novel strategies to protect us from xenobiotic insults.

[1]  H. Rosing,et al.  Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics , 2006, Clinical Cancer Research.

[2]  M. Hayden,et al.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. , 2005, The Journal of clinical investigation.

[3]  H. Faulstich,et al.  Identification of phalloidin uptake systems of rat and human liver. , 2004, Biochimica et biophysica acta.

[4]  Richard J. Thompson,et al.  Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency , 2006, Hepatology.

[5]  Hiroshi Omote,et al.  A human transporter protein that mediates the final excretion step for toxic organic cations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Hirotaka Matsuo,et al.  Molecular identification of a renal urate–anion exchanger that regulates blood urate levels , 2002, Nature.

[7]  T. Gilliam,et al.  Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. , 1999, Human molecular genetics.

[8]  C. Klaassen,et al.  Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[9]  D D Breimer,et al.  Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. , 2000, The Journal of clinical investigation.

[10]  P. Borst,et al.  Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.

[11]  P. Dawson,et al.  Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). , 1997, The Journal of clinical investigation.

[12]  J. Sundberg,et al.  Targeted Ablation of the Abcc6 Gene Results in Ectopic Mineralization of Connective Tissues , 2005, Molecular and Cellular Biology.

[13]  P. Borst,et al.  Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Stuart J McLarnon,et al.  Iron handling and gene expression of the divalent metal transporter, DMT1, in the kidney of the anemic Belgrade (b) rat. , 2003, Kidney international.

[15]  P. Dawson,et al.  The Heteromeric Organic Solute Transporter α-β, Ostα-Ostβ, Is an Ileal Basolateral Bile Acid Transporter* , 2005, Journal of Biological Chemistry.

[16]  C. Klaassen,et al.  Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[17]  Kim L R Brouwer,et al.  The Important Role of Bcrp (Abcg2) in the Biliary Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Mice , 2006, Molecular Pharmacology.

[18]  N. Amizuka,et al.  Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Choudhuri,et al.  Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[20]  Jonathan C. Cohen,et al.  ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M500115-JLR200 , 2005, Journal of Lipid Research.

[21]  K. Millen,et al.  Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. , 2006, Endocrinology.

[22]  H. Kusuhara,et al.  Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. , 2004, Endocrinology.

[23]  L. Thurfjell,et al.  Mapping Pathological 99mTc-d,l-Hexamethylpropylene Amine Oxime Uptake in Alzheimer’s Disease and Frontal Lobe Dementia with SPECT , 2001, Dementia and Geriatric Cognitive Disorders.

[24]  R. Palmiter,et al.  Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Masuda Functional characteristics and pharmacokinetic significance of kidney-specific organic anion transporters, OAT-K1 and OAT-K2, in the urinary excretion of anionic drugs. , 2003, Drug metabolism and pharmacokinetics.

[26]  S. Vavricka,et al.  Regional Distribution of Solute Carrier mRNA Expression Along the Human Intestinal Tract , 2007, Drug Metabolism and Disposition.

[27]  P. Wielinga,et al.  Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy , 2004, Molecular and Cellular Biology.

[28]  N. Ballatori Biology of a Novel Organic Solute and Steroid Transporter, OSTΑ-OSTβ , 2005 .

[29]  V. Divoky,et al.  Functional consequences of the human DMT1 (SLC11A2) mutation on protein expression and iron uptake. , 2005, Blood.

[30]  M. Kool,et al.  Peptide transport by the multidrug resistance protein MRP1. , 2001, Cancer research.

[31]  Y. Sugiyama,et al.  Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats. , 2002, American journal of physiology. Endocrinology and metabolism.

[32]  J. Schellens,et al.  Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[33]  J. Schuetz,et al.  The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme* , 2004, Journal of Biological Chemistry.

[34]  Y. Asano,et al.  P-glycoprotein-mediated drug secretion in mouse proximal tubule perfused in vitro. , 2001, Journal of the American Society of Nephrology : JASN.

[35]  F. Kuipers,et al.  Dietary plant sterols accumulate in the brain. , 2006, Biochimica et biophysica acta.

[36]  R. Keep,et al.  Role and Relevance of Peptide Transporter 2 (PEPT2) in the Kidney and Choroid Plexus: In Vivo Studies with Glycylsarcosine in Wild-Type and PEPT2 Knockout Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.

[37]  J. Mercer,et al.  ATP7B mediates vesicular sequestration of copper: insight into biliary copper excretion. , 2006, Gastroenterology.

[38]  Jae-Young Koh,et al.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Wijnholds,et al.  Multidrug Resistance Protein 1 Protects the Oropharyngeal Mucosal Layer and the Testicular Tubules against Drug-induced Damage , 1998, The Journal of experimental medicine.

[40]  P. Dawson,et al.  The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. , 2005, The Journal of biological chemistry.

[41]  A. Klein-Szanto,et al.  Analysis of the In Vivo Functions of Mrp3 , 2005, Molecular Pharmacology.

[42]  L. Pawlikowska,et al.  Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport , 2006, Hepatology.

[43]  Xingguo Cheng,et al.  TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE , 2005, Drug Metabolism and Disposition.

[44]  A. Schinkel,et al.  Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations , 2003, Molecular and Cellular Biology.

[45]  Per Artursson,et al.  Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines , 2007, Drug Metabolism and Disposition.

[46]  P. Borst,et al.  Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene , 2005, Hepatology.

[47]  G. Mitchell,et al.  Carnitine transport by organic cation transporters and systemic carnitine deficiency. , 2001, Molecular genetics and metabolism.

[48]  Z. Gregus,et al.  Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[49]  T. Abe,et al.  Identification and characterization of novel rat and human gonad-specific organic anion transporters. , 2003, Molecular endocrinology.

[50]  W. Fung-Leung,et al.  ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. , 2001, Gastroenterology.

[51]  C. Ackerley,et al.  Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. Abe,et al.  Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Boyer,et al.  Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis , 2006, Hepatology.

[54]  V. Vallon,et al.  Decreased Renal Organic Anion Secretion and Plasma Accumulation of Endogenous Organic Anions in OAT1 Knock-out Mice* , 2006, Journal of Biological Chemistry.

[55]  H. Koepsell,et al.  Reduced Hepatic Uptake and Intestinal Excretion of Organic Cations in Mice with a Targeted Disruption of the Organic Cation Transporter 1 (Oct1 [Slc22a1]) Gene , 2001, Molecular and Cellular Biology.

[56]  O. van Tellingen,et al.  Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. , 1999, The Journal of clinical investigation.

[57]  H. Rosing,et al.  The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  N. Ballatori Biology of a novel organic solute and steroid transporter, OSTalpha-OSTbeta. , 2005, Experimental biology and medicine.

[59]  Yuichi Sugiyama,et al.  Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. , 2007, Journal of the American Society of Nephrology : JASN.

[60]  C. Klaassen,et al.  Intestinal absorption of cadmium is associated with divalent metal transporter 1 in rats. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[61]  R. Palmiter,et al.  Mouse zinc transporter 1 gene provides an essential function during early embryonic development , 2004, Genesis.

[62]  Jonathan C. Cohen,et al.  Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[63]  B. Neuschwander‐Tetri,et al.  The hepatocellular bile acid transporter Ntcp facilitates uptake of the lethal mushroom toxin α-amanitin , 2004, Archives of Toxicology.

[64]  P. Dawson,et al.  Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in Mice* , 2003, Journal of Biological Chemistry.

[65]  A. Bonci,et al.  The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference , 2004, Nature Neuroscience.

[66]  N. Maeda,et al.  A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol , 2004, BMC medicine.

[67]  Yuichi Sugiyama,et al.  Characterization of the Uptake of Organic Anion Transporter (OAT) 1 and OAT3 Substrates by Human Kidney Slices , 2007, Journal of Pharmacology and Experimental Therapeutics.

[68]  Yuichi Sugiyama,et al.  Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal Lumen , 2005, Molecular Pharmacology.

[69]  Yuichi Sugiyama,et al.  Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir , 2007, Molecular Pharmacology.

[70]  P. Bosma,et al.  Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Jianjun Liu,et al.  Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis* , 2004, Journal of Biological Chemistry.

[72]  R. Keep,et al.  Targeted Disruption of the PEPT2 Gene Markedly Reduces Dipeptide Uptake in Choroid Plexus* , 2003, The Journal of Biological Chemistry.

[73]  V. Ling,et al.  Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. , 2005, Biochemistry.

[74]  F. Russel,et al.  Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter. , 2004, Journal of the American Society of Nephrology : JASN.

[75]  Peter J. Meier,et al.  Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties , 2004, Pflügers Archiv.

[76]  A. Dahan,et al.  Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[77]  D. Beier,et al.  Impaired Organic Anion Transport in Kidney and Choroid Plexus of Organic Anion Transporter 3 (Oat3 (Slc22a8)) Knockout Mice* , 2002, The Journal of Biological Chemistry.

[78]  V. Ling,et al.  Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P‐glycoprotein , 2003, Hepatology.

[79]  G. L. Youngblood,et al.  Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. , 2004, American journal of physiology. Renal physiology.

[80]  T. Visser,et al.  Mechanisms of Disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8 , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[81]  C. Klaassen,et al.  The presence of xenobiotic transporters in rat placenta. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[82]  R. Kim,et al.  Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans , 2007, Clinical pharmacology and therapeutics.

[83]  H. Kusuhara,et al.  Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[84]  S. Brennecke,et al.  The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[85]  Luquan Wang,et al.  Materials and Methods Figs. S1 to S4 Tables S1 and S2 References Niemann-pick C1 like 1 Protein Is Critical for Intestinal Cholesterol Absorption , 2022 .